Clinical Trial Update: Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) [Phase 2]

View source ↗

Summary

Phase 2 study of tovorafenib for high-grade glioma with BRAF aberration and diffuse intrinsic pontine glioma; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• High-grade Glioma
• Who Glioma

Drugs mentioned

• tovorafenib (tovorafenib)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV) | Phase 2 | Status: NOT_YET_RECRUITING